Integrated Cf-miRNA and Exosomal miRNA Signature for Early Detection of Esophageal Squamous Cell Carcinoma

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

Esophageal squamous cell carcinoma (ESCC) remains a highly lethal cancer worldwide, largely due to late diagnosis. Current screening methods such as upper endoscopy are invasive, operator-dependent, and limited in their ability to detect early-stage lesions. To address this clinical need, the SYNERGY study seeks to develop a non-invasive, blood-based biomarker assay that integrates cell-free microRNAs (cf-miRNAs) and exosomal microRNAs (exo-miRNAs) to detect ESCC at an early and potentially curable stage. This multicenter translational study includes discovery, training, and validation phases using preoperative plasma or serum samples. By combining the tumor specificity of exosomal miRNAs with the systemic sensitivity of cf-miRNAs, SYNERGY aims to construct a robust diagnostic model with high sensitivity and specificity for early ESCC detection.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Osoby w wieku od 18 do 90 lat.
  • Potwierdzony rak płaskonabłonkowy przełyku.
  • Brak wcześniejszego leczenia przed pobraniem próbki krwi.
  • Osoby zdrowe do grupy kontrolnej (bez chorób nowotworowych).

✗ Disqualifies

  • Brak zgody na udział w badaniu.
  • Niewystarczająca ilość lub jakość próbki krwi.
  • Inny rak w ciągu ostatnich 5 lat (chyba że był ograniczony do jednego miejsca).
  • Aktywne, ogólnoustrojowe zapalenie, które może wpływać na wyniki badania krwi.

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
July 7, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (1)

City of Hope Medical Center

Monrovia, United States

Trial contact

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/8/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.